---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-024862"
form_type: "8-K"
ticker: "LMAT"
cik: "0001158895"
company_name: "LEMAITRE VASCULAR INC"
filed_at: "2025-08-05T23:59:59+00:00"
generated_at: "2026-05-17T20:27:51.113619+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# LeMaitre Vascular Q2 sales up 15% to $64.2M; raises FY guidance

## Summary
- Q2 EPS $0.60 (+16% YoY); sales $64.2M (+15% organic) driven by catheters (+27%) and grafts (+19%).
- Gross margin 70.0% (+110 bps); operating income $16.1M (+12%).
- Full-year guidance raised: sales $248-$254M (midpoint +14%), EPS $2.23-$2.37 (midpoint +19%).
- Quarterly dividend of $0.20/share declared, payable Sept 4, 2025 to holders of record Aug 21.
- Cash increased $16.9M sequentially to $319.5M; $75M share repurchase program active through Feb 2026.

## SEC filing metadata
- accession: 0001437749-25-024862
- form_type: 8-K
- ticker: LMAT
- cik: 0001158895
- company_name: LEMAITRE VASCULAR INC
- filed_at: 2025-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1158895/000143774925024862/0001437749-25-024862-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1158895/000143774925024862/lmat20250805_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-024862
- JSON: https://secwatch.observer/filing/0001437749-25-024862.json
- Plain text: https://secwatch.observer/filing/0001437749-25-024862.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.